Management of Hodgkin Lymphoma in a Sickle Cell Patient: A Case Report.
Chemotherapy
Hodgkin lymphoma
Sickle cell disease
Journal
Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601
Informations de publication
Date de publication:
Historique:
received:
29
01
2019
accepted:
30
01
2019
entrez:
24
4
2019
pubmed:
24
4
2019
medline:
24
4
2019
Statut:
epublish
Résumé
Sickle cell disease (SCD) is an inherited disorder of hemoglobin mutation in red blood cells, with a patient population that is increasing in age in recent decades due to advances in modern medicine. Hodgkin's lymphoma (HL) is a cancer of white blood cells, and while concomitance of SCD and Hodgkin's has been reported, a discussion of treatment for HL in SCD is lacking from the literature. We present a case of effectively treated HL in SCD and put forth that the regimen used is a practical choice, and as it was completed fully as outpatient, it improved the patient's quality of life compared to an inpatient regimen.
Identifiants
pubmed: 31011320
doi: 10.1159/000497480
pii: cro-0012-0224
pmc: PMC6465740
doi:
Types de publication
Case Reports
Langues
eng
Pagination
224-227Références
Blood. 2007 Oct 1;110(7):2727-35
pubmed: 17600133
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 2:S63-6
pubmed: 18284718
Biol Blood Marrow Transplant. 2008 Jun;14(6):719-23
pubmed: 18489998
Cytotherapy. 2009;11(4):464-71
pubmed: 19513902
Blood. 2010 Apr 29;115(17):3447-52
pubmed: 20194891
Blood. 2011 Mar 3;117(9):2596-603
pubmed: 21079154
Lancet. 2012 Sep 1;380(9844):836-47
pubmed: 22835602
Case Rep Hematol. 2013;2013:146938
pubmed: 24396616
J R Soc Med. 2016 Aug;109(8):303-9
pubmed: 27325377
Blood. 2016 Sep 8;128(10):1436-8
pubmed: 27439910
N Engl J Med. 2017 Apr 20;376(16):1561-1573
pubmed: 28423290
Blood. 2017 Sep 28;130(13):1597-1599
pubmed: 28830890
Int J Hematol Oncol Stem Cell Res. 2017 Oct 1;11(4):286-292
pubmed: 29340124